Evidence of association of human papillomavirus with prognosis worsening in glioblastoma multiforme

Neuro-Oncology

Volumn 16, Issue 2, 2014, Pages 298-302

  Vidone, Michele ^a   Alessandrini, Federica ^b   Marucci, Gianluca ^b   Farnedi, Anna ^b   De Biase, Dario ^c   Ricceri, Fulvio ^d   Calabrese, Claudia ^a   Kurelac, Ivana ^a   Porcelli, Anna Maria ^b   Cricca, Monica ^b   Gasparre, Giuseppe ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c BELLARIA HOSPITAL   (Italy)

^d MAURIZIANO HOSPITAL   (Italy)

Author keywords

glioblastoma multiforme; HPV; prognosis

Indexed keywords

CAPSID PROTEIN; DNA; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; CANCER CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA VIRUS; FEMALE; GENOME; GLIOBLASTOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 6; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; RETROSPECTIVE STUDY; WART VIRUS;

GLIOBLASTOMA MULTIFORME; HPV; PROGNOSIS;

ADULT; AGED; BRAIN NEOPLASMS; CAPSID PROTEINS; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 6; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84893149762     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/not140     Document Type: Article

References (23)

1. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008; 359(5):492-507.
2. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996.
3. Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459-466.
4. Dziurzynski K, Chang SM, Heimberger AB, et al. Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol. 2012;14(3): 246-255.
5. Del Valle L, Gordon J, Assimakopoulou M, et al. Detection of JC virus DNA sequences and expression of the viral regulatory protein T-antigen in tumors of the central nervous system. Cancer Res. 2001;61(10): 4287-4293.
6. Gravitt PE, Peyton CL, Alessi T, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000;38(1):357-361.
7. Capone RB, Pai SI, KochWM, et al. Detection and quantitation of human papilloma virus (HPV) in the sera of patients with HPV-associated Head and Neck Squamous cell carcinoma. Clin Cancer Res. 2000;6(11): 4171-4175.
8. Bodaghi S, Wood LV, Roby G, et al. Could human papillomaviruses be spread through blood? J Clin Microbiol. 2005;43(11):5428-5434.
9. Chen J, Tsai V, Parker WE, Aronica E, Baybis M, Crino PB. Detection of Human Papillomavirus in human focal cortical dysplasia Type IIB. Ann Neurol. 2012;72(6):881-892.
10. Mohammadi A, Pfeifer JD, Lewis JS Jr. Association between human papillomavirus DNA and temporal arteritis. BMC Musculoskelet Disord. 2012;13:132.
11. Ducray F, Idbaih A, Wang XW, Cheneau C, Labussiere M, Sanson M. Predictive and prognostic factors for gliomas. Expert Rev Anticancer Ther. 2011;11(5):781-789.
12. Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352(10): 997-1003.
13. de Boer MA, Jordanova ES, Kenter GG, et al. Highhumanpapillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients. Clin Cancer Res. 2007;13: 132-138.
14. Lee LA, Huang CG, Liao CT , et al. Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. Plos One. 2012;7(7):e40767.
15. Rautava J, Kuuskoski J, Syrjanen K, Grenman R, Syrjanen S. HPV genotypes and their prognostic significance in head and neck squamous cell carcinomas. J Clin Virol. 2012;53(2):116-120.
16. Yhim HY, Lee NR, Song EK, et al. The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy. Int J Cancer. 2011;129(7):1752-1760.
17. FakhryC,WestraWH, Li S, etal. Improvedsurvivalof patientswithhuman papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100(4):261-269.
18. Ohgaki H, Dessen P, Jourde B, et al. Genetic pathways to glioblastoma: A population-based study. Cancer Res. 2004;64(19):6892-6899.
19. Korshuno A, Sycheva R, Golanov A. The prognostic relevance of molecular alterations in glioblastomas for patients age ,50 years. Cancer. 2005;104(4):825-832.
20. Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer. 2010;10(8):550-560.
21. Muller M, Gissmann L, Cristiano RJ, et al. Papillomavirus capsid binding and uptake by cells from different tissues and species. J Virol. 1995; 69(2):948-954.
22. Properzi F, Lin R, Kwok J, et al. Heparan sulphate proteoglycans in glia and in the normal and injured CNS: expression of sulphotransferases and changes in sulphation. Eur J Neurosci. 2008;27(3):593-604.
23. Campo MS, Roden RB. Papillomavirus prophylactic vaccines: established successes, new approaches. J Virol. 2010;84(3):1214-1220.